A Study Testing the Effect and Safety of Casopitant (GW679769) While Taking Warfarin in Healthy Human Volunteers

NCT00404274 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

97

Enrollment

INDUSTRY

Sponsor class

Conditions

Nausea and Vomiting, Chemotherapy-Induced

Interventions

DRUG: Casopitant (GW679769) oral tablets
DRUG: Warfarin oral tablets

Sponsor

GlaxoSmithKline